Literature DB >> 19395959

The role of MD-2 in the opsonophagocytosis of Gram-negative bacteria.

Pierre Tissières1, Jérôme Pugin.   

Abstract

PURPOSE OF REVIEW: The identification of human Toll-like receptors has drastically changed our understanding of host-pathogen interactions. This review presents recent data on myeloid differentiation factor 2 (MD-2), a membrane-bound and soluble receptor for Gram-negative lipopolysaccharide, and its central role in the recognition of Gram-negative bacteria, phagocytosis, and Toll-like receptor 4 signalling. RECENT
FINDINGS: Phagocytosis is a complex mechanism involving a variety of receptors and opsonins. The heterogeneity of phagocytic mechanisms allows the optimization of bacteria recognition, phagocytosis, and killing. Notably, Toll-like receptors were known to play a role in phagocytosis, both by modulating opsonins and phagocytosis receptors' expression and activity, and by contributing to bacterial recognition and presentation to host cells. Recent data provide additional insight into the function of Toll-like receptors and associated proteins. In addition to bacterial recognition and activation of inflammatory cascades, MD-2 has been recently shown to be an opsonin for Gram-negative bacteria and an acute-phase protein. These newly described characteristics directly link Gram-negative bacteria recognition, transduction of Toll-like receptor 4 inflammatory signalling, phagocytosis and bacterial clearance.
SUMMARY: Recent progress in the understanding of Gram-negative bacteria recognition by host cells as well as physiologic functionality of MD-2 suggests that MD-2 is a critical compound in host response to pathogens and plays a central role in physiologic adaptation to various insults.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19395959     DOI: 10.1097/QCO.0b013e32832ae2fc

Source DB:  PubMed          Journal:  Curr Opin Infect Dis        ISSN: 0951-7375            Impact factor:   4.915


  5 in total

Review 1.  S-nitrosylation of surfactant protein D as a modulator of pulmonary inflammation.

Authors:  Elena N Atochina-Vasserman
Journal:  Biochim Biophys Acta       Date:  2011-12-13

2.  Structural and biological characteristics of different forms of V. filiformis lipid A: use of MS to highlight structural discrepancies.

Authors:  Aude Breton; Alexey Novikov; Richard Martin; Pierre Tissieres; Martine Caroff
Journal:  J Lipid Res       Date:  2017-01-25       Impact factor: 5.922

3.  Cooperation between PU.1 and CAAT/enhancer-binding protein beta is necessary to induce the expression of the MD-2 gene.

Authors:  Pierre Tissières; Tanguy Araud; Agnieszka Ochoda; Geneviève Drifte; Irène Dunn-Siegrist; Jérôme Pugin
Journal:  J Biol Chem       Date:  2009-07-24       Impact factor: 5.157

4.  Innate immune deficiency of extremely premature neonates can be reversed by interferon-γ.

Authors:  Pierre Tissières; Agnieszka Ochoda; Irène Dunn-Siegrist; Geneviève Drifte; Michel Morales; Riccardo Pfister; Michel Berner; Jérôme Pugin
Journal:  PLoS One       Date:  2012-03-12       Impact factor: 3.240

5.  Genome of Acanthamoeba castellanii highlights extensive lateral gene transfer and early evolution of tyrosine kinase signaling.

Authors:  Michael Clarke; Amanda J Lohan; Bernard Liu; Ilias Lagkouvardos; Scott Roy; Nikhat Zafar; Claire Bertelli; Christina Schilde; Arash Kianianmomeni; Thomas R Bürglin; Christian Frech; Bernard Turcotte; Klaus O Kopec; John M Synnott; Caleb Choo; Ivan Paponov; Aliza Finkler; Chris Soon Heng Tan; Andrew P Hutchins; Thomas Weinmeier; Thomas Rattei; Jeffery S C Chu; Gregory Gimenez; Manuel Irimia; Daniel J Rigden; David A Fitzpatrick; Jacob Lorenzo-Morales; Alex Bateman; Cheng-Hsun Chiu; Petrus Tang; Peter Hegemann; Hillel Fromm; Didier Raoult; Gilbert Greub; Diego Miranda-Saavedra; Nansheng Chen; Piers Nash; Michael L Ginger; Matthias Horn; Pauline Schaap; Lis Caler; Brendan J Loftus
Journal:  Genome Biol       Date:  2013-02-01       Impact factor: 13.583

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.